Active Observation as an Alternative to Invasive Treatments for Pediatric Head and Neck Lymphatic Malformations
- 27 October 2020
- journal article
- research article
- Published by Wiley in The Laryngoscope
- Vol. 131 (6) , 1392-1397
Abstract
Objectives: An increasing number of treatment modalities for lymphatic malformations are being described, complicating therapeutic decisions. Understanding lymphatic malformation natural history is essential. We describe management of head and neck lymphatic malformations where decisions primarily addressed lesion‐induced functional compromise (ie, breathing, swallowing) to identify factors associated with invasive treatment and active observation. We hypothesize that non‐function threatening malformations can be observed.Study Design: Retrospective case series.Methods: Retrospective case series of consecutive head and neck lymphatic malformation patients (2000–2017) with over 2 years of follow‐up. Patient characteristics were summarized and associations with invasive treatment (surgery or sclerotherapy) tested using Fisher's exact. In observed patients, factors associated with spontaneous regression were assessed with Fisher's exact test.Results: Of 191 patients, 101 (53%) were male, 97 (51%) Caucasian, and 98 (51.3%) younger than 3 months. Malformations were de Serres I–III 167 (87%), or IV–V 24 (12%), and commonly located in the neck (101, 53%), or oral cavity (36, 19%). Initial treatments included observation (65, 34%) or invasive treatments such as primary surgery (80, 42%), staged surgery (25, 13%), or primary sclerotherapy (9, 5%). Of 65 initially observed malformations, 8 (12%) subsequently had invasive treatment, 36 (58%) had spontaneous regression, and 21 (32%) elected for no invasive therapy. Spontaneous regression was associated with location in the lateral neck (P = .003) and macrocystic malformations (P = .017).Conclusion: Head and neck lymphatic malformation treatment selection can be individualized after stratifying by stage, presence of functional compromise, and consideration of natural history. Recognizing the spectrum of severity is essential in evaluating efficacy of emerging treatments, as selected malformations may respond to observation.Level of Evidence: 4 Laryngoscope, 131:1392–1397, 2021Keywords
This publication has 26 references indexed in Scilit:
- Clinical application of molecular genetics in lymphatic malformationsLaryngoscope Investigative Otolaryngology, 2019
- Vascular Anomalies in PediatricsAdvances in Pediatrics, 2015
- The Lymphatic Malformation Function (LMF) InstrumentOtolaryngology–Head and Neck Surgery, 2015
- Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular AnomaliesPediatrics, 2015
- Lymphatic and Other Vascular Malformative/Overgrowth Disorders Are Caused by Somatic Mutations in PIK3CAThe Journal of Pediatrics, 2015
- Standardized Outcome and Reporting Measures in Pediatric Head and Neck Lymphatic MalformationsOtolaryngology–Head and Neck Surgery, 2015
- Prognostic Value of a Simplified Anatomically Based Nomenclature for Fetal Nuchal Lymphatic AnomaliesOtolaryngology–Head and Neck Surgery, 2014
- Head and Neck Lymphatic Malformation TreatmentOtolaryngology–Head and Neck Surgery, 2012
- Clinical Outcomes in Lymphocytopenic Lymphatic Malformation PatientsLymphatic Research and Biology, 2007
- Pediatric Admissions and Procedures for Lymphatic Malformations in the United States: 1997 and 2000Lymphatic Research and Biology, 2005